CFF: CFF/NIH R01 Unfunded Award
Cystic Fibrosis Foundation
Want a reminder before this closes?
We'll email you 3 days before the deadline. One email, then we stop.
Free. Verify your email, then we send one reminder only.
- Posted
- Jun 28, 2026
- Amount
- $125,000
- Closes
- Nov 30, 2026 (in 66 days)
Similar opportunities open now
- CFF: Path to a Cure Pioneer AwardSame funderOpenCystic Fibrosis FoundationCloses Dec 5, 2026 (in 71 days)
- CFF: Travel Award SupplementSame funderOpenCystic Fibrosis FoundationCloses Nov 16, 2026 (in 52 days)Up to $3K
- CFF: Student Traineeship AwardSame funderOpenCystic Fibrosis FoundationCloses Nov 16, 2026 (in 52 days)Up to $4K
- Reissue of RFA-FD-22-001 - Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases (R01 Clinical Trials Optional)OpenFood and Drug AdministrationCloses Feb 2028Up to $600K
- Reissue of RFA-FD-23-001- Clinical Studies of Orphan Products Addressing Unmet Needs of Rare Diseases (R01 Clinical Trials Required)OpenFood and Drug AdministrationCloses May 2028Up to $900K
Amount
$125,000
Who can apply
Individuals can apply here. Check the eligibility details below to see if your organization fits.
Investigators with questions about their eligibility or chance of success within this program are encouraged to reach out to the program officer.As a result of funding constraints on governmental agencies in the United States and other countries, coupled with the growing interest in cystic fibrosis research, occasions arise in which highly meritorious grant applications are submitted to these governmental agencies but are not funded. or international) with an NIH R01-equivalent funding program that provides reviewer critiques and a report indicating the application received an impact score between 1-45 In both cases, the applications must be able to be resubmitted to the funding agency within one year of receiving a CFF/NIH R01-Unfunded Award to be eligible for consideration.Note: Fellowsh...
About this opportunity
Purpose: To provide bridge funding for CF-relevant R01 (or equivalent) applications that were submitted to NIH (or other governmental agencies) that scored in the 40th percentile but were not awarded by the funding agency. The objective of this award is to support excellent cystic fibrosis-related research projects that have been approved by the National Institutes of Health (or governmental funding agencies in other countries) but cannot be supported by available funds. Current eligibility allows researchers with an Impact Score (or equivalent) between 1–45 to apply for this mechanism. This includes grants with a status of "competitive not discussed" status. Investigators with questions about their eligibility or chance of success within this program are encouraged to reach out to the pro...